23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A high burden of asymptomatic genital tract infections undermines the syndromic management approach among adolescents and young adults in South Africa: implications for HIV prevention efforts

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Youth in southern Africa, particularly adolescent girls and young women, are a key population for HIV prevention interventions. Untreated genital tract infections (GTIs) increase both HIV transmission and acquisition risks. South African GTI treatment guidelines employ syndromic management, which relies on individuals to report GTI signs and symptoms. Syndromic management may, however, underestimate cases, particularly among youth. We compared genital tract infection (GTI) prevalence by symptom-based and laboratory assessment among sexually-experienced youth in South Africa, overall and stratified by sex.

          Methods

          Interviewer-administered surveys assessed socio-demographics, behaviors, and GTI symptoms among 352 youth (16-24 yrs., HIV-negative or unknown HIV status at enrollment) enrolled in community-based cohorts in Durban and Soweto (2014–2016). Laboratory tests assessed HIV, Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma genitalium (MG), Trichomonas vaginalis (TV) infections and, among females, bacterial vaginosis (BV) and Candida species. Youth with genital ulcers were tested for HSV-2 and syphilis. We assessed sensitivity (and specificity) of symptom-based reporting in identifying laboratory-confirmed GTIs.

          Results

          At baseline, 16.2% of females (32/198) and < 1% (1/154) of males reported ≥1 GTI symptom. However, laboratory tests identified ≥1 GTI in 70.2% and 10.4%, respectively. Female CT prevalence was 18.2%, NG 7.1%, MG 9.6%, TV 8.1%, and 5.1% were newly diagnosed with HIV. BV prevalence was 53.0% and candidiasis 9.6%. One female case of herpes was identified (0 syphilis). Male CT prevalence was 7.8%, NG 1.3%, MG 3.3%, TV < 1%, and 2.0% were newly diagnosed with HIV. Overall, 77.8% of females and 100% of males with laboratory-diagnosed GTIs reported no symptoms or were asymptomatic. Sensitivity (and specificity) of symptom-based reporting was 14% (97%) among females and 0% (99%) among males.

          Conclusion

          A high prevalence of asymptomatic GTIs and very poor sensitivity of symptom-based reporting undermines the applicability of syndromic GTI management, thus compromising GTI control and HIV prevention efforts among youth. Syndromic GTI management does not meet the sexual health needs of young people. Policy changes incorporating innovations in GTI diagnostic testing are needed to reduce GTIs and HIV-associated risks among youth.

          Electronic supplementary material

          The online version of this article (10.1186/s12879-018-3380-6) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references21

          • Record: found
          • Abstract: found
          • Article: not found

          Contribution of sexually transmitted infections to the sexual transmission of HIV.

          We review recent evidence about the link between sexually transmitted infections (STI) and HIV transmission and consider implications for control programmes. New studies and meta-analyses confirm the association of HIV acquisition and transmission with recent STIs, although there is considerable heterogeneity between organisms and populations. Much of the recent evidence relates to herpes simplex virus type 2 (HSV-2), for which the population-attributable risk percentage (PAR%) for HSV-2 is between 25 and 35 in Africa. Mathematical models show how transmission attributable to STI varies with HIV epidemic phase, and HSV-2 becomes increasingly important as the epidemic matures. HSV-2 suppressive therapy reduces HIV concentrations in plasma and the genital tract in people coinfected with HSV-2, in part due to direct inhibition of HIV reverse transcriptase. Recent trials of HSV-2 suppressive therapy have not shown an impact on the risk of HIV acquisition, nor in controlling transmission from dually infected people to their serodiscordant heterosexual partners. Although there is a plausible link between STI and HIV risk, intervention studies continue to be disappointing. This fact does not disprove a causal link, but mechanisms of action and the design and implementation of interventions need to be better understood.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Performance of the Cepheid CT/NG Xpert Rapid PCR Test for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae.

            Tests for Chlamydia trachomatis and Neisseria gonorrhoeae, which can provide results rapidly to guide therapeutic decision-making, offer patient care advantages over laboratory-based tests that require several days to provide results. We compared results from the Cepheid GeneXpert CT/NG (Xpert) assay to results from two currently approved nucleic acid amplification assays in 1,722 female and 1,387 male volunteers. Results for chlamydia in females demonstrated sensitivities for endocervical, vaginal, and urine samples of 97.4%, 98.7%, and 97.6%, respectively, and for urine samples from males, a sensitivity of 97.5%, with all specificity estimates being ≥ 99.4%. Results for gonorrhea in females demonstrated sensitivities for endocervical, vaginal, and urine samples of 100.0%, 100.0%, and 95.6%, respectively, and for urine samples from males, a sensitivity of 98.0%, with all estimates of specificity being ≥ 99.8%. These results indicate that this short-turnaround-time test can be used to accurately test patients and to possibly do so at the site of care, thus potentially improving chlamydia and gonorrhea control efforts.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Beyond syndromic management: Opportunities for diagnosis-based treatment of sexually transmitted infections in low- and middle-income countries

              Introduction In light of the limited impact the syndromic management approach has had on the global sexually transmitted infection (STI) epidemic, we assessed a care model comprising point-of-care (POC) STI testing, immediate treatment, and expedited partner therapy (EPT) among a cohort of young women at high HIV risk in South Africa. Methods and findings HIV negative women presenting for STI care underwent POC testing for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Trichomonas vaginalis (TV), and swabs were sent for NG culture and susceptibility testing. Results were available within 2 hours and women with STIs were immediately treated and offered EPT packs, including medication, condoms, and information for sexual partners. An EPT questionnaire was administered after one week, and women retested for STIs after 6 and 12 weeks. 267 women, median age 23 (IQR 21–26), were recruited and 88.4% (236/267) reported genital symptoms. STI prevalence was CT 18.4% (95%CI 13.7–23.0), NG 5.2% (95%CI 2.6–7.9) and TV 3.0% (95%CI 1.0–5.0). After 12 weeks, all but one NG and two CT infections were cleared. No cephalosporin-resistant NG was detected. Of 63/267 women (23.6%) diagnosed with STIs, 98.4% (62/63) were offered and 87.1% (54/62) accepted EPT. At one week 88.9% (48/54) stated that their partner had taken the medication. No allergic reactions or social harms were reported. Of 51 women completing 6-week follow up, detection rates were lower amongst women receiving EPT (2.2%, 1/46) compared to those who did not (40.0%, 2/5), p = 0.023. During focus group discussions women supported the care model, because they received a rapid, specific diagnosis, and could facilitate their partners’ treatment. Conclusions POC STI testing and EPT were acceptable to young South African women and their partners, and could play an important role in reducing STI reinfection rates and HIV risk. Larger studies should evaluate the feasibility and cost-effectiveness of implementing this strategy at population level.
                Bookmark

                Author and article information

                Contributors
                778-782-9068 , kangela@sfu.ca
                dietrichj@phru.co.za
                laherf@phru.co.za
                mbeksinska@mru.ac.za
                mjaggernath@mru.ac.za
                Megan.bardsley@phe.gov.uk
                tricia2679@yahoo.com
                laura.cotton@bastyr.edu
                pchitneni@mgh.harvard.edu
                kvenditt@sfu.ca
                david.lewis2@sydney.edu.au
                jsmit@matchresearch.co.za
                Thumbi.Ndungu@ahri.org
                mark_brockman@sfu.ca
                Glenda.Gray@mrc.ac.za
                Journal
                BMC Infect Dis
                BMC Infect. Dis
                BMC Infectious Diseases
                BioMed Central (London )
                1471-2334
                3 October 2018
                3 October 2018
                2018
                : 18
                : 499
                Affiliations
                [1 ]ISNI 0000 0004 1936 7494, GRID grid.61971.38, Faculty of Health Sciences, , Simon Fraser University, ; Blusson Hall Rm 10522, 8888 University Drive, Burnaby, B.C. V5A 1S6 Canada
                [2 ]ISNI 0000 0004 1937 1135, GRID grid.11951.3d, Perinatal HIV Research Unit (PHRU), Faculty of Health Sciences, , University of the Witwatersrand, ; Johannesburg, South Africa
                [3 ]ISNI 0000 0004 1937 1135, GRID grid.11951.3d, Maternal Adolescent and Child Health (MatCH) Research Unit (MRU), Faculty of Health Sciences, , University of the Witwatersrand, ; Durban, South Africa
                [4 ]ISNI 0000 0004 0425 469X, GRID grid.8991.9, London School of Hygiene and Tropical Medicine, ; London, UK
                [5 ]Harvard combined Infectious Diseases Fellowship, Boston, MA USA
                [6 ]ISNI 0000 0004 0630 4574, GRID grid.416657.7, Centre for HIV and STIs, , National Institute for Communicable Diseases, ; Johannesburg, South Africa
                [7 ]ISNI 0000 0004 1936 834X, GRID grid.1013.3, Faculty of Medicine and Health & Marie Bashir Institute for Infectious Diseases and Biosecurity, , University of Sydney, ; Sydney, Australia
                [8 ]ISNI 0000 0001 0723 4123, GRID grid.16463.36, HIV Pathogenesis Programme and Africa Health Research Institute, , University of KwaZulu-Natal, ; Durban, South Africa
                [9 ]ISNI 0000 0004 0489 3491, GRID grid.461656.6, Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, ; Cambridge, MA USA
                [10 ]ISNI 0000 0004 0491 2699, GRID grid.418159.0, Max Planck Institute for Infection Biology, ; Berlin, Germany
                [11 ]ISNI 0000 0000 9155 0024, GRID grid.415021.3, South African Medical Research Council, ; Cape Town, South Africa
                Author information
                http://orcid.org/0000-0003-0329-1926
                Article
                3380
                10.1186/s12879-018-3380-6
                6171143
                30285705
                6c774a6d-5f9c-439a-b779-43f0ec3e5a0c
                © The Author(s). 2018

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 30 July 2018
                : 13 September 2018
                Funding
                Funded by: Canadian HIV Vaccine Initiative (CHVI)
                Award ID: N/A
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100001322, South African Medical Research Council;
                Award ID: N/A
                Award Recipient :
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2018

                Infectious disease & Microbiology
                adolescents and young adults,youth,women,sexually transmitted infections,genital tract infections,hiv prevention,screening,syndromic management,performance analysis,south africa

                Comments

                Comment on this article